Impact of adverse drug reactions on the treatment pathways of early rheumatoid arthritis patients: a prospective observational cohort study.

Kimberly VelthuisFenna PoppelaarsPeter M Ten Klooster Harald E Vonkeman Naomi T Jessurun

Published in: Expert opinion on drug safety (2023)

Treatment pathways increase in complexity over time. Differences were found between patients with and without ADRs, with patients that experience ADRs receiving more and shorter treatments.

Keyphrases

rheumatoid arthritis patients
adverse drug
ejection fraction
newly diagnosed
disease activity
prognostic factors
electronic health record
systemic lupus erythematosus
patient reported outcomes